The Changing Landscape of Risk Management in Pharmaceuticals and Biotechnology Industry
The biggest risk in the pharmaceutical and bio sector was ‘disruption to sales activities and the supply system.’ The results were the same in 2016 and six years later in 2022. However, while there were concerns in the past about the risk of ‘market recession’ and ‘loss of brand value’, recently the importance of cyber […]